{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:22:05Z","timestamp":1790313725886,"version":"4.1.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3,1]]},"abstract":"<jats:p>Adenocarcinoma of the esophagogastric junction (AEG) has a high incidence, and the extent of lymph node dissection (LND) and its impact on prognosis remain controversial. This study aimed to explore the risk factors for lymph node metastasis (LNM) and prognosis in Siewert II\/III AEG patients. A retrospective review of 239 Siewert II\/III AEG patients surgically treated at Beijing Friendship Hospital from July 2013 to December 2022 was conducted. Preoperative staging was conducted via endoscopy, ultrasound gastroscopy, CT, and biopsy. Depending on the stage, patients received radical gastrectomy with LND and chemotherapy. Clinicopathological data were collected, and survival was monitored semiannually until November 2023. Utilizing logistic regression for data analysis and Cox regression for survival studies, multivariate analysis identified infiltration depth (OR\u2005=\u20050.038, 95% CI: 0.011\u20130.139, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001), tumor deposit (OR\u2005=\u20050.101, 95% CI: 0.011\u20130.904, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.040), and intravascular cancer embolus (OR\u2005=\u20050.234, 95% CI: 0.108\u20130.507, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001) as independent predictors of LNM. Lymph nodes No. 1, 2, 3, 4, 7, 10, and 11 were more prone to metastasis in the abdominal cavity. Notably, Siewert III AEG patients showed a higher metastatic rate in nodes No. 5 and No. 6 compared to Siewert II. Mediastinal LNM was predominantly found in nodes No. 110 and No. 111 for Siewert II AEG, with rates of 5.45% and 3.64%, respectively. A 3-year survival analysis underscored LNM as a significant prognostic factor (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.001). Siewert II AEG patients should undergo removal of both celiac and mediastinal lymph nodes, specifically nodes No. 1, 2, 3, 4, 7, 10, 11, 110, and 111. Dissection of nodes No. 5 and No. 6 is not indicated for these patients. In contrast, Siewert III AEG patients do not require mediastinal LND, but pyloric lymphadenectomy for nodes No. 5 and No. 6 is essential. The presence of LNM is associated with poorer long-term prognosis. Perioperative chemotherapy may offer a survival advantage for AEG patients.<\/jats:p>","DOI":"10.1097\/md.0000000000037289","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T01:00:10Z","timestamp":1709341210000},"page":"e37289","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Assessment of risk factors of lymph node metastasis and prognosis of Siewert II\/III adenocarcinoma of esophagogastric junction: A retrospective study"],"prefix":"10.1097","volume":"103","author":[{"given":"Yidong","family":"Huang","sequence":"first","affiliation":[{"name":"Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China"},{"name":"Beijing Key Laboratory of Cancer Invasion and Metastasis Research & National Clinical Research Center for Digestive Diseases, Xi-Cheng District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0390-9466","authenticated-orcid":false,"given":"Zhi","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China"},{"name":"Beijing Key Laboratory of Cancer Invasion and Metastasis Research & National Clinical Research Center for Digestive Diseases, Xi-Cheng District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqiao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China"},{"name":"Beijing Key Laboratory of Cancer Invasion and Metastasis Research & National Clinical Research Center for Digestive Diseases, Xi-Cheng District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China"},{"name":"Beijing Key Laboratory of Cancer Invasion and Metastasis Research & National Clinical Research Center for Digestive Diseases, Xi-Cheng District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoye","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China"},{"name":"Beijing Key Laboratory of Cancer Invasion and Metastasis Research & National Clinical Research Center for Digestive Diseases, Xi-Cheng District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China"},{"name":"Beijing Key Laboratory of Cancer Invasion and Metastasis Research & National Clinical Research Center for Digestive Diseases, Xi-Cheng District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongtao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China"},{"name":"Beijing Key Laboratory of Cancer Invasion and Metastasis Research & National Clinical Research Center for Digestive Diseases, Xi-Cheng District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1245\/s10434-016-5426-6","article-title":"What\u2019s the best way to treat ge junction tumors? approach like gastric cancer.","volume":"23","author":"Mullen","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"9637972","DOI":"10.1155\/2019\/9637972","article-title":"Proximal gastrectomy versus total gastrectomy for siewert type II adenocarcinoma of the esophagogastric junction: a comprehensive analysis of data from the SEER registry.","volume":"2019","author":"Zhu","year":"2019","journal-title":"Dis Markers"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/jso.23799","article-title":"Clinicopathological features and prognosis of gastric cardia adenocarcinoma: a multi-institutional US study.","volume":"111","author":"Amini","year":"2015","journal-title":"J Surg Oncol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00595-019-01843-4","article-title":"True esophagogastric junction adenocarcinoma: background of its definition and current surgical trends.","volume":"50","author":"Kumamoto","year":"2020","journal-title":"Surg Today"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1186\/s12885-019-5922-8","article-title":"The optimal extent of lymph node dissection in gastroesophageal junctional cancer: retrospective case control study.","volume":"19","author":"Han","year":"2019","journal-title":"BMC Cancer"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/bjs.9764","article-title":"Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia.","volume":"102","author":"Kurokawa","year":"2015","journal-title":"Br J Surg"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.suronc.2017.11.004","article-title":"The optimal lymph node dissection in patients with adenocarcinoma of the esophagogastric junction.","volume":"27","author":"Okholm","year":"2018","journal-title":"Surg Oncol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"E264","DOI":"10.1111\/ans.13980","article-title":"Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: a retrospective study of 136 cases.","volume":"88","author":"Duan","year":"2018","journal-title":"ANZ J Surg"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10120-014-0439-y","article-title":"Theoretical therapeutic impact of lymph node dissection on adenocarcinoma and squamous cell carcinoma of the esophagogastric junction.","volume":"19","author":"Yoshikawa","year":"2016","journal-title":"Gastric Cancer"},{"issue":"Suppl 1","key":"R11-20250504","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10120-016-0663-8","article-title":"Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma.","volume":"20","author":"Yamashita","year":"2017","journal-title":"Gastric Cancer"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.surg.2014.08.099","article-title":"Mediastinal lymph node metastasis and recurrence in adenocarcinoma of the esophagogastric junction.","volume":"157","author":"Kurokawa","year":"2015","journal-title":"Surgery"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1245\/s10434-011-1983-x","article-title":"Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.","volume":"19","author":"Hosokawa","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijsu.2017.03.028","article-title":"Prognostic significance of the number of lymph nodes examined in node-negative Siewert type II esophagogastric junction adenocarcinoma.","volume":"41","author":"Wu","year":"2017","journal-title":"Int J Surg"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10120-016-0601-9","article-title":"Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project.","volume":"20","author":"Sano","year":"2017","journal-title":"Gastric Cancer"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jtho.2016.10.016","article-title":"Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer.","volume":"12","author":"Rice","year":"2017","journal-title":"J Thorac Oncol"},{"key":"R18-20250504","first-page":"237","article-title":"Lymph node metastasis and lymphadenectomy of resectable adenocarcinoma of the esophagogastric junction.","volume":"26","author":"Chen","year":"2014","journal-title":"Chin J Cancer Res"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1200\/JCO.2009.22.2083","article-title":"Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer.","volume":"27","author":"Allum","year":"2009","journal-title":"J Clin Oncol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10120-010-0555-2","article-title":"Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies.","volume":"13","author":"Hasegawa","year":"2010","journal-title":"Gastric Cancer"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"e18451","DOI":"10.1097\/MD.0000000000018451","article-title":"Priority of lymph node dissection for advanced esophagogastric junction adenocarcinoma with the tumor center located below the esophagogastric junction.","volume":"98","author":"Cai","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s11748-014-0381-2","article-title":"Optimal surgical management for esophagogastric junction carcinoma.","volume":"62","author":"Matsuda","year":"2014","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00268-017-3880-3","article-title":"Clinicopathological characteristics and prognostic factors of patients with siewert type II esophagogastric junction carcinoma: a retrospective multicenter study: reply.","volume":"41","author":"Matsuda","year":"2017","journal-title":"World J Surg"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12957-016-1088-x","article-title":"Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma.","volume":"15","author":"Lee","year":"2017","journal-title":"World J Surg Oncol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5230\/jgc.2012.12.1.36","article-title":"Outcomes of abdominal total gastrectomy for type II and III gastroesophageal junction tumors: single center\u2019s experience in Korea.","volume":"12","author":"Kim","year":"2012","journal-title":"J Gastric Cancer"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s11605-018-3935-2","article-title":"Should pyloric lymph nodes be dissected for siewert type II and III adenocarcinoma of the esophagogastric junctions: experience from a high-volume center in China.","volume":"23","author":"Cao","year":"2019","journal-title":"J Gastrointest Surg"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/SLA.0b013e3182263911","article-title":"Optimal extent of lymph node dissection for Siewert type II esophagogastric junction carcinoma.","volume":"254","author":"Yamashita","year":"2011","journal-title":"Ann Surg"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S1470-2045(06)70766-5","article-title":"Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial.","volume":"7","author":"Sasako","year":"2006","journal-title":"Lancet Oncol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.ejso.2017.08.017","article-title":"The prognostic relevance of parapyloric lymph node metastasis in Siewert type II\/III adenocarcinoma of the esophagogastric junction.","volume":"43","author":"Wang","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"R30-20250504","first-page":"4605","article-title":"Explored Risk Factors for Lymph Node Metastasis with Siewert II\/III Adenocarcinoma of the Gastroesophageal Junction.","volume":"37","author":"Zheng","year":"2017","journal-title":"Anticancer Res"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"6945743","DOI":"10.1155\/2018\/6945743","article-title":"The characteristics, prognosis, and risk factors of lymph node metastasis in early gastric cancer.","volume":"2018","author":"Li","year":"2018","journal-title":"Gastroenterol Res Pract"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.3748\/wjg.v13.i38.5133","article-title":"Risk factors for lymph node metastasis and evaluation of reasonable surgery for early gastric cancer.","volume":"13","author":"Xu","year":"2007","journal-title":"World J Gastroenterol"},{"key":"R33-20250504","first-page":"14150","article-title":"A study on related risk factors and prognosis for lymph node metastasis in patients with early gastric cancer.","volume":"9","author":"Yin","year":"2016","journal-title":"Int J Clin Exp Med"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.ejso.2018.10.062","article-title":"Evaluation of the impact of tumor deposits on prognosis in gastric cancer and a proposal for their incorporation into the AJCC staging system.","volume":"44","author":"Chen","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12957-022-02507-3","article-title":"Association of tumor deposits with tumor-infiltrating lymphocytes and prognosis in gastric cancer.","volume":"20","author":"Li","year":"2022","journal-title":"World J Surg Oncol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1245\/s10434-010-1152-7","article-title":"Lymph node negative colorectal cancers with isolated tumor deposits should be classified and treated as stage III.","volume":"17","author":"Belt","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1186\/s12885-019-6112-4","article-title":"Risk evaluation of splenic hilar or splenic artery lymph node metastasis and survival analysis for patients with proximal gastric cancer after curative gastrectomy: a retrospective study.","volume":"19","author":"Ding","year":"2019","journal-title":"BMC Cancer"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s101200050006","article-title":"Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer.","volume":"1","author":"Kim","year":"1998","journal-title":"Gastric Cancer"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0959-8049(99)00308-1","article-title":"Prognostic factors after curative resection for gastric cancer. A population-based study.","volume":"36","author":"Msika","year":"2000","journal-title":"Eur J Cancer"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"9248394","DOI":"10.1155\/2019\/9248394","article-title":"Clinicopathological characteristics and prognosis of upper gastric cancer patients in china: a 32-year single-center retrospective clinical study.","volume":"2019","author":"Gong","year":"2019","journal-title":"Gastroenterol Res Pract"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.suronc.2018.07.008","article-title":"Analysis of the clinicopathological features and prognostic factors in 734 cases of Chinese Hui and Han patients with adenocarcinoma of the esophagogastric junction.","volume":"27","author":"Cao","year":"2018","journal-title":"Surg Oncol"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.","volume":"355","author":"Cunningham","year":"2006","journal-title":"N Engl J Med"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/sj.bjc.6602573","article-title":"A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients.","volume":"92","author":"De Vita","year":"2005","journal-title":"Br J Cancer"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1200\/JCO.2009.26.6114","article-title":"Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.","volume":"28","author":"Schuhmacher","year":"2010","journal-title":"J Clin Oncol"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1200\/JCO.2010.33.0597","article-title":"Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial.","volume":"29","author":"Ychou","year":"2011","journal-title":"J Clin Oncol"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJMoa072252","article-title":"Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.","volume":"357","author":"Sakuramoto","year":"2007","journal-title":"N Engl J Med"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S1470-2045(14)70473-5","article-title":"Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial.","volume":"15","author":"Noh","year":"2014","journal-title":"Lancet Oncol"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejca.2017.04.027","article-title":"Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): long-term results of a controlled randomised trial.","volume":"81","author":"Stahl","year":"2017","journal-title":"Eur J Cancer"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037289","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T03:12:23Z","timestamp":1746328343000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037289","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,1]]}}}